Session

Overview: Quantitative imaging biomarkers (QIBs) derived from MRI techniques have the potential to personalize radiotherapy treatment. QIBs can be utilized in various ways, including for treatment planning, adaptation of treatment plan during treatment, and response assessment after radiotherapy. Furthermore, they can be used to guide contouring as they can show good tumour visibility. However, introducing QIBs is not trivial and a lot of steps need to be taken before QIBs can be used clinically to personalize radiotherapy treatments. This symposium contains speakers from both the ESTRO and ISMRM community to discuss the use of quantitative MRI in radiotherapy.